FDA official suggests potential connection between COVID-19 vaccines and pediatric fatalities

Dr. Vinay Prasad, head of the Food and Drug Administration's vaccine division, circulated a memo to staff claiming that COVID-19 vaccines were associated with the deaths of children, though he did not provide supporting data. According to sources familiar with the memo, it stated that a review "found that at least 10 children have died after and because of receiving COVID-19 vaccination."

The memo, first reported by the New York Times, suggested that the deaths may be related to myocarditis, an inflammation of the heart muscle. However, Prasad did not disclose the review's data, such as the ages of the children, any pre-existing health conditions, or the method used to determine a connection between the deaths and vaccination. The findings have not been published in any peer-reviewed medical journal.

While myocarditis has been linked to COVID-19 vaccines, pediatric cardiologists have emphasized that the risk is much higher following a coronavirus infection. Studies indicate that myocarditis caused by vaccination generally has a more favorable prognosis compared with infection-related cases. COVID-19 infection itself can also result in long-term complications.

Research suggests that the risk of myocarditis is higher when vaccine doses are administered close together, which was common when COVID-19 vaccines were first introduced. Current recommendations space doses roughly a year apart, and for children who receive the primary series before age five, the risk is almost negligible. Both Pfizer and Moderna vaccines include warnings about myocarditis and pericarditis. In April 2025, these warnings were updated for males aged 16 to 25. At the time, the FDA reported approximately 8 cases of myocarditis or pericarditis per million doses for children and adults under 65.

COVID-19 vaccines, initially developed under the Trump administration, have become a focus of scrutiny under the current administration. Records indicate that top FDA officials appointed by Health and Human Services Secretary Robert F. Kennedy Jr. overrode career staff to restrict approvals for Novavax and Moderna vaccines. A CDC official overseeing vaccine guidance resigned in June after being directed to revise recommendations by Kennedy.

Changes to vaccination guidance have created public confusion. In September, the CDC's Advisory Committee on Immunization Practices (ACIP), composed entirely of Kennedy appointees, updated its recommendations, emphasizing individualized decisions without explicitly endorsing the vaccine. Meanwhile, the American Academy of Pediatrics strongly recommends COVID-19 vaccination for children aged 6 months to 2 years, and the Infectious Diseases Society of America supports vaccination for all individuals six months and older. Some states have issued guidance that differs from the CDC through regional public health alliances.

Dr. Cline Gounder, a CBS News medical contributor, noted in August that public messaging around vaccines has been chaotic, urging parents to "stick the course" and consult their doctors to ensure children receive all recommended vaccinations, including the initial COVID-19 series.

Analysis of Recent Memo Regarding COVID-19 Vaccines and Child Deaths

The recent memo circulated by Dr. Vinay Prasad, head of the FDA's vaccine division, has raised concerns among both the public and medical community. The memo, which claims a link between COVID-19 vaccines and the deaths of children, has caused significant attention, despite the absence of concrete data. Dr. Prasad mentioned that at least 10 children died "after and because of" receiving the COVID-19 vaccine, but did not provide any specifics on the methodology, ages, or pre-existing health conditions of those involved. This lack of transparency and peer-reviewed evidence has led to skepticism about the validity of these claims.

The memo suggested that myocarditis, a heart condition linked to the vaccine, may be a contributing factor. However, pediatric cardiologists have emphasized that the risk of myocarditis following COVID-19 vaccination is relatively low compared to the risk of developing it after a COVID-19 infection. Studies have shown that vaccine-related myocarditis generally has a better prognosis than infection-related cases. This contrast underscores the importance of considering the broader context of COVID-19 vaccination, where the benefits outweigh the risks, particularly for children.

Furthermore, Dr. Prasad's memo highlights the need for clearer public health guidance. Current research indicates that spacing out vaccine doses reduces the risk of myocarditis, and recent changes to dosing schedules and recommendations for children have lowered these risks significantly. While myocarditis warnings remain on both Pfizer and Moderna vaccines, these concerns must be weighed against the continued threat of COVID-19, which can cause long-term complications, including heart-related issues.

The ongoing debate regarding vaccine policy has also been influenced by political changes within the FDA and CDC, with top officials appointed by Robert F. Kennedy Jr. overreaching to restrict approvals for certain vaccines. The varying guidance from different health organizations, such as the American Academy of Pediatrics and the CDC, has led to public confusion, further complicated by shifting recommendations that do not clearly endorse the vaccine. This chaotic messaging makes it difficult for the public to trust the health system and follow recommended guidelines.

In conclusion, while the concerns raised in Dr. Prasad's memo merit further investigation, the broader context of COVID-19 vaccination suggests that the risks remain low compared to the benefits. Continued transparency, along with clear and consistent messaging, is essential to ensure public trust in vaccination efforts and maintain progress in combating the pandemic.

Sources:

• FDA official claims link between COVID-19 vaccines and pediatric deaths